Life Science Leader Magazine Supplements

CMO 2016

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/646761

Contents of this Issue

Navigation

Page 56 of 63

K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2016 CMO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2016 57 CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science INDIVIDUAL ATTRIBUTE AWARDS: on-time, right first time, strength of science INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science DRUG TYPE: Pharmaceuticals DRUG TYPE: Pharmaceuticals, Biopharmaceuticals DRUG TYPE: Pharmaceuticals, Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging "The Helsinn Group is celebrating its 40th anniversary in 2016 and believes its core values of respect, integrity, and quality have been the backbone of four decades of success in helping patients enjoy a better quality of life. These core values are echoed in the CMO Leadership categories and Helsinn is honored to be the recipient of awards in the following categories: quality, reliability, capabilities, expertise, and compatibility." "We would like to thank our customers and the Life Science Leader for recognizing Kemwell as a winner in all five categories. We look forward to serving our current and new customers with increased depth of services in 2016 and support them to bring their high quality products to the patients. We are launching GMP manufacturing for clinical batches from our North Carolina site especially for non-sterile inhaled products (MDI, DPI, Nasal), oral liquids, topicals, and oral solids." SERVICES & CAPABILITIES: controlled substances, cytotoxic & high potency compounds, generics, ophthalmics, peptides, powders (non-sterile) SERVICES & CAPABILITIES: capsules, generics, injectables, liquids, soft gels, solid dose SERVICES & CAPABILITIES: aseptic fill/ finish, capsules, creams & ointments, gels, generics, inhaled dosage forms, injectables, liquids, lyophilized products, nonsterile, OTC, parenterals (large volume), parenterals (small volume), peptides, powders (non-sterile), proteins, semisolids, solid dose, solutions & suspensions, sterile, sustained release, topicals WALDO MOSSI General Manager B PARADHASARADHI REDDY Chairman & Managing Director ANURAG BAGARIA Chariman & Managing Director CATEGORIES WON CATEGORIES WON CATEGORIES WON Kemwell Biopharma Morrisville, NC www.kemwellbiopharma.com +1 919 884 2064 Gregory Downs gregory.downs@cirruspharm.com Key locations: Bangalore, India; Uppsula, Sweden; Research Triangle Park, North Carolina, U.S.A. Hetero Labs Limited Hyderabad, Telangana, India www.heteroworld.com +91 40 23704923/24/25 Dr Vasudev Jadhav vasudev.j@heterodrugs.com Key locations: Hyderabad, Vishakapatnam, Baddi, Pune Helsinn Advanced Synthesis SA Biasca, Switzerland www.helsinn.com +011 41 91 873 94 00 Sandra Moro Sandra.Moro@helsinn.com Key locations: Biasca, Switzerland "In a span of over two decades, we have successfully emerged as one of India's leading generic pharmaceutical companies and one of the world's largest producers of anti-retroviral drugs for the treatment of HIV/AIDS. Started as an API manufacturer at the nascent stage, we evolved our businesses and are now focusing on generics, biosimilars and CPS. Our company is recognized for its strengths in research and development, manufacturing, and commercialization for various products."

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2016